Pradžia › Limfedema › New York
Limfedema klinikiniai tyrimai New York
5 tyrimai dėl Limfedema ieško dalyvių vietose New York.
Miestai New York
Oficialus tyrimo tekstas (anglų kalba)
A Study Comparing Quality of Life in Patients With Lymphedema Who Undergo Surgical Treatment Versus Non-Surgical Management
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- Memorial Sloan Kettering Nassau (Limited Protocol Activites), Rockville Centre
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-24 · NCT03248310A Post-market, Real-world Experience: Expanding Access to Care by Incorporating the Symani® Surgical System and Enabling Surgeons
- Erie County Medical Center, Buffalo
- Icahn School of Medicine at Mount Sinai, New York
Renkami dalyviaiStebimasis tyrimas
Amžius 22 ir vyresni · Visoms lytims · Atnaujinta 2026-09-11 · NCT06725030Lymphedema Surveillance Study
- Memorial Sloan Kettering Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- ir dar 1
Renkami dalyviaiStebimasis tyrimas
Amžius 18 ir vyresni · Moterims · Atnaujinta 2026-05-07 · NCT02743858Clinical Study to Evaluate the Effectiveness and Health Economics of a Novel Portable Non-Pneumatic Active Compression Device (NPCD) for Lymphedema/Phlebolymphedema
- Glenn Jacobowitz, New York
Renkami dalyviai
Amžius nuo 18 iki 100 · Visoms lytims · Atnaujinta 2026-05-04 · NCT06418282A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer
- Memorial Sloan Kettering Commack (Limited Protocol Activities), Commack
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
- ir dar 1
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Moterims · Atnaujinta 2025-11-10 · NCT06144164Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.